Showing 71 - 80 of 236
Persistent link: https://www.econbiz.de/10007890206
Objectives: An increasing emphasis on patient-centred health care and shared decision making requires an intensive consideration of patient preferences. In the present study, patient preferences regarding treatment of HIV/AIDS were explored using direct assessment and discrete choice experiment...
Persistent link: https://www.econbiz.de/10010148186
Objective: Osteoporotic fractures impose a huge economic burden on society. Though several cost of illness studies from other countries exist, no equivalent study has been conducted in Austria. Our study aims at assessing costs resulting from osteoporotic fractures in Austria in the year 2008...
Persistent link: https://www.econbiz.de/10010030031
Persistent link: https://www.econbiz.de/10009331606
Pharmaceutical firms frequently attract political attention due to their high accounting profitability. We study the U.S. pharmaceutical industry to test the two opposing views of how regulators use accounting information in the political process: The “public interest hypothesis” predicts...
Persistent link: https://www.econbiz.de/10014140245
The Korean government believes it can turn the country into one of the top 10 competitive economies by 2010. This volume offers an in-depth analysis of the Korean innovation system and shows how its science and technology policies actually work. As Korea's economy is now reaching the status of a...
Persistent link: https://www.econbiz.de/10013520825
The Challenge of Innovation and Technology for Korea as a Newly Advanced Economy Revisited -- Moving to the innovation frontier: Lessons from the OECD Review of Korean Innovation Policy -- Korea’s New Techno-Scientific Strategy: Realigning State, Market and Society to Move beyond Technological...
Persistent link: https://www.econbiz.de/10013522942
During the past 20 years, the world pharmaceutical industry has experienced a dramatic increase in R&D intensity. We apply and extend a model developed by Grabowski and Vernon (2000, Journal of Evolutionary Economics, <Emphasis Type="Bold">10, 201–215) with a pooled data sample of the 15 publicly listed Japanese...</emphasis>
Persistent link: https://www.econbiz.de/10005705054
Persistent link: https://www.econbiz.de/10008480596
We analyze how Japanese pharmaceutical firms internationalized their research and development (R&D) investments during the 1980 and 1990s. In order to tap into foreign knowledge bases, they heavily invested in setting up R&D centers abroad. However, knowledge transfer, evidenced by international...
Persistent link: https://www.econbiz.de/10009191072